Fredag 27 December | 17:19:40 Europe / Stockholm
Svenska | English
Investor Relations
Public Relations

Neola Medical

Bifogade filer

Kursutveckling under dagen för detta pressmeddelande (SEK).

Likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

Tid*
2025-02-12 08:00 Bokslutskommuniké 2024
2024-11-06 - Kvartalsrapport 2024-Q3
2024-08-15 - Kvartalsrapport 2024-Q2
2024-05-23 - X-dag ordinarie utdelning NEOLA 0.00 SEK
2024-05-22 - Årsstämma
2024-05-22 - Kvartalsrapport 2024-Q1
2024-02-14 - Bokslutskommuniké 2023
2023-12-29 - Extra Bolagsstämma 2023
2023-11-09 - Kvartalsrapport 2023-Q3
2023-08-15 - Kvartalsrapport 2023-Q2
2023-05-19 - X-dag ordinarie utdelning NEOLA 0.00 SEK
2023-05-17 - Årsstämma
2023-05-17 - Kvartalsrapport 2023-Q1
2023-02-14 - Bokslutskommuniké 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-09-27 - Extra Bolagsstämma 2022
2022-08-16 - Kvartalsrapport 2022-Q2
2022-05-20 - X-dag ordinarie utdelning NEOLA 0.00 SEK
2022-05-19 - Årsstämma
2022-05-19 - Kvartalsrapport 2022-Q1
2022-02-15 - Bokslutskommuniké 2021
2021-11-09 - Kvartalsrapport 2021-Q3
2021-09-14 - Extra Bolagsstämma 2021
2021-08-17 - Kvartalsrapport 2021-Q2
2021-05-21 - X-dag ordinarie utdelning NEOLA 0.00 SEK
2021-05-20 - Årsstämma
2021-05-20 - Kvartalsrapport 2021-Q1
2021-02-16 - Bokslutskommuniké 2020
2020-11-11 - Kvartalsrapport 2020-Q3

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Neola Medical är verksamt inom medicinteknik. Bolaget är inriktade mot neonatalvården där de utvecklar medicinteknisk utrustning. Exempel på produkter som bolaget tillhandahåller till sjukvården inkluderar teknisk övervakning och uppföljning av lungkapaciteten hos tidigt födda spädbarn. Utöver huvudprodukten erbjuds kringprodukter och engångsartiklar. Störst verksamhet återfinns inom den nordiska marknaden. Bolaget gick tidigare under namnet GPX Medical.
Neola Medical invites to presentation of the Q2-report 2024
2024-08-06 13:50:00

Neola Medical AB (publ) invites to presentation of the Q2-report of 2024, Thursday the 15th of August 2024 at 12:30 CET (12.30). The presentation will be held online as a webcast hosted by Finwire. The Q2-report will be published the same morning.

Neola Medical publishes the Q2-report in the morning the 15th of August 2024. We hereby invite investors, analysts, and journalists to a combined report presentation and webcast Thursday the 15th of August 2024 at 12:30 CET (12.30). The report will be presented by CEO Hanna Sjöström and CFO Christian Gyllenberg.

Watch the presentation here: https://www.finwire.tv/webcast/neola-medical/q2-2024/ where you also can type in questions in advance and during the presentation that we will be answering live during the Q&A after the presentation.

For further questions after the presentation, contact CFO Christian Gyllenberg through below contact details.

The report and report presentation will be available at Neola Medical’s website:
https://www.neolamedical.com/investors/rapporter-och-finansiell-kalender/

For further information, contact:
Hanna Sjöström, CEO
e-mail: hanna.sjostrom@neolamedical.com
Christian Gyllenberg, CFO
e-mail: christian.gyllenberg@neolamedical.com

About Neola Medical
Neola Medical AB (publ) develops revolutionizing medical technology device for non-invasive continuous lung monitoring and real-time alerts of life-threatening lung complications of preterm born infants. Immediate detection of complications provides the possibility of early treatment, improved health care and healthier lives for preterm born infants. The patented cutting-edge technology is developed at Lund University in Sweden and based on a spectroscopic method that measures lung volume changes and oxygen gas concentration. Neola Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care. The company was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at www.neolamedical.com. The company’s Certified Adviser is FNCA Sweden AB.

Attachments
Neola Medical invites to presentation of the Q2-report 2024

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden